Clinical Trial Update: Safety and Efficacy of Faricimab in Patients With NPDR [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update assessing Faricimab in non-proliferative diabetic retinopathy, focusing on safety and efficacy outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-proliferative Diabetic Retinopathy

Drugs mentioned

• Faricimab (faricimab)

Snippet

Sponsor: Greater Houston Retina Research | Conditions: Non-Proliferative Diabetic Retinopathy | Phase 2 | Status: COMPLETED